Stay updated on Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The clinical-trial record for a Phase 2 study of pembrolizumab with or without defactinib for resectable pancreatic cancer is displayed, with study details, participant criteria, and outcome measures. The record indicates the study is completed and no longer seeking participants.
    Difference
    53%
    Check dated 2026-11-08T04:42:00.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T01:40:43.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A banner announces an NIH-wide transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T01:46:25.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T01:30:08.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T02:06:02.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Removed the 403 Forbidden error content from the study record page. Also removed the Home navigation item from the footer/navigation.
    Difference
    0.5%
    Check dated 2026-09-27T01:43:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Defactinib in Pancreatic Cancer Clinical Trial page.